BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31462102)

  • 1. An update on current and future treatment options for chondrosarcoma.
    MacDonald IJ; Lin CY; Kuo SJ; Su CM; Tang CH
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):773-786. PubMed ID: 31462102
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological aspects of chondrosarcoma: Leaps and hurdles.
    Mery B; Espenel S; Guy JB; Rancoule C; Vallard A; Aloy MT; Rodriguez-Lafrasse C; Magné N
    Crit Rev Oncol Hematol; 2018 Jun; 126():32-36. PubMed ID: 29759564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma.
    van Oosterwijk JG; Anninga JK; Gelderblom H; Cleton-Jansen AM; Bovée JV
    Hematol Oncol Clin North Am; 2013 Oct; 27(5):1021-48. PubMed ID: 24093174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
    Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
    Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor-alpha receptor expression supports the growth of conventional chondrosarcoma and is associated with adverse outcome.
    Sulzbacher I; Birner P; Trieb K; Mühlbauer M; Lang S; Chott A
    Am J Surg Pathol; 2001 Dec; 25(12):1520-7. PubMed ID: 11717542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma.
    Sun L; Li Y; Jiang Z; Zhang J; Li H; Li B; Ye Z
    Tumour Biol; 2016 Jun; 37(6):7333-44. PubMed ID: 26676633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance.
    Boehme KA; Schleicher SB; Traub F; Rolauffs B
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion.
    Yuan J; Dutton CM; Scully SP
    J Orthop Res; 2005 Nov; 23(6):1467-74. PubMed ID: 15927440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gefitinib causes growth arrest and inhibition of metastasis in human chondrosarcoma cells.
    Song J; Zhu J; Zhao Q; Tian B
    J BUON; 2015; 20(3):894-901. PubMed ID: 26214645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic chondrosarcomas: surgical treatment options.
    Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
    Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort.
    Thorkildsen J; Taksdal I; Bjerkehagen B; Haugland HK; Børge Johannesen T; Viset T; Norum OJ; Bruland Ø; Zaikova O
    Acta Oncol; 2019 Mar; 58(3):273-282. PubMed ID: 30632866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.
    Sun X; Charbonneau C; Wei L; Chen Q; Terek RM
    Mol Cancer Res; 2015 Sep; 13(9):1347-57. PubMed ID: 26013170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment.
    Bovée JV; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC
    Lancet Oncol; 2005 Aug; 6(8):599-607. PubMed ID: 16054571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chondrosarcoma of the foot. Apropos of a case--literature review].
    Jarde O; Desablens B; Marie A; Vives P
    Acta Orthop Belg; 1991; 57(4):452-5. PubMed ID: 1772026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells.
    Tzeng HE; Chang AC; Tsai CH; Wang SW; Tang CH
    Oncotarget; 2016 Jun; 7(25):38566-38578. PubMed ID: 27229532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrosarcoma of bone: an assessment of outcome.
    Lee FY; Mankin HJ; Fondren G; Gebhardt MC; Springfield DS; Rosenberg AE; Jennings LC
    J Bone Joint Surg Am; 1999 Mar; 81(3):326-38. PubMed ID: 10199270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondrosarcoma of bone.
    Leddy LR; Holmes RE
    Cancer Treat Res; 2014; 162():117-30. PubMed ID: 25070233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondrosarcomas of digits: are they really malignant?
    Mankin HJ
    Cancer; 1999 Nov; 86(9):1635-7. PubMed ID: 10547534
    [No Abstract]   [Full Text] [Related]  

  • 19. Chondrosarcoma: biology, genetics, and epigenetics.
    Chow WA
    F1000Res; 2018; 7():. PubMed ID: 30519452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dedifferentiated chondrosarcoma arising from osteochondromatosis. A case report.
    Du YK; Shih HN; Wang JM; Shih CH
    Changgeng Yi Xue Za Zhi; 1991 Jun; 14(2):130-5. PubMed ID: 1878807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.